- Home
- MTC vs MBRX Comparison
MTC vs MBRX Comparison
Compare MTC & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTC
- MBRX
- Stock Information
- Founded
- MTC 2015
- MBRX 2015
- Country
- MTC Hong Kong
- MBRX United States
- Employees
- MTC N/A
- MBRX N/A
- Industry
- MTC Computer Software: Prepackaged Software
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- MTC Technology
- MBRX Health Care
- Exchange
- MTC Nasdaq
- MBRX Nasdaq
- Market Cap
- MTC 26.4M
- MBRX 24.3M
- IPO Year
- MTC 2019
- MBRX 2016
- Fundamental
- Price
- MTC $0.86
- MBRX $0.48
- Analyst Decision
- MTC
- MBRX Strong Buy
- Analyst Count
- MTC 0
- MBRX 4
- Target Price
- MTC N/A
- MBRX $5.00
- AVG Volume (30 Days)
- MTC 765.2K
- MBRX 2.8M
- Earning Date
- MTC 09-12-2025
- MBRX 11-07-2025
- Dividend Yield
- MTC N/A
- MBRX N/A
- EPS Growth
- MTC N/A
- MBRX N/A
- EPS
- MTC N/A
- MBRX N/A
- Revenue
- MTC $2,675,833.00
- MBRX N/A
- Revenue This Year
- MTC N/A
- MBRX N/A
- Revenue Next Year
- MTC N/A
- MBRX N/A
- P/E Ratio
- MTC N/A
- MBRX N/A
- Revenue Growth
- MTC 114.77
- MBRX N/A
- 52 Week Low
- MTC $0.76
- MBRX $0.25
- 52 Week High
- MTC $5.10
- MBRX $3.65
- Technical
- Relative Strength Index (RSI)
- MTC 42.99
- MBRX 53.68
- Support Level
- MTC $0.80
- MBRX $0.42
- Resistance Level
- MTC $0.88
- MBRX $0.55
- Average True Range (ATR)
- MTC 0.04
- MBRX 0.04
- MACD
- MTC -0.00
- MBRX 0.01
- Stochastic Oscillator
- MTC 37.34
- MBRX 59.68
About MTC MMTec Inc.
MMTEC Inc provides Internet-based technology services and solutions to the Chinese language speaking hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms engaging in securities market transactions and settlements globally. It offers complete suite trading solutions, including services such as fund establishment, issuance, custody, transaction, and settlement. The Company currently has two operating segments, Gujia, MM Future, HC Securities, and MM Global. It generates maximum revenue from the Gujia segment. Gujia segment provides market data services and investor relations management services to customers in China.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.